Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Stress-mediated activation of the hypothalamic-pituitary axis (HPA) enables adaptation to immune-mediated inflammation. A candidate central mediator of this effect is the growth and differentiation factor LIF, which we have previously shown to be expressed in pituitary tissue in-vivo and to induce ACTH in-vitro. As both hypothalamic and pituitary LIF and LIF-receptor are expressed in-vivo, we determined LIF action on POMC transcription with a POMC-luc construct (-706/+64). 1 nM LIF induced POMC transcription by 200%, compared to 540% for 10 nM CRH, while the combination of LIF and CRH strikingly enhanced POMC induction -20-fold. The LIF-related cytokine oncostatin M (l nM) was also a weak agonist of POMC transcription (160% induction), and also potently synergised witb CRH (10-fold induction). CRH acts through adcnylate cyclase, and both forskolin and 8bromo cAMP also stimulated POMC transcription (270%), while addition of 1 nM LIF was again synergistic (740% induction). Transaction of 3' POMC deletion mutants revealed a critical LIF/CRH response region between -323 and -166. However, the combination of LIF and CRH still stimulated expression of a -323/-166 deleted POMC construct to 270% of control, possibly through the recently defined AP-1 site within the non-coding exon 1. Sitedirected mutagenesis of this AP-1 site, while reducing basal activity of the promoter to 60% of wild-type, did not alter LIF, CRH or UF/CRH responses, suggesting that the 5' flanking region of POMC between -323 and -166 was solely responsible for conferring POMC transcriptional responsiveness to LIF as POMC contains no typical cytokine response element. These results demonstrate a direct effect of LIF on the POMC gene in marked synergy with CRH, indicating the presence of a potent central cytokine-mediated response at the level of the pituitary corticotroph.

Type

Conference paper

Publication Date

01/01/1996

Volume

44